GC17644
Bortezomib
Also listed as Bortezomib (PS-341)
Bortezomib (PS-341), as a dipeptide boronic acid proteasome inhibitor with antitumor activity, can potently inhibiit 20S proteasome with Ki of 0·6 nM by targeting a threonine residue
ChemicalCAS179324-69-7MW384.24FormulaC19H25BN4O4
- CAS number
- 179324-69-7
- Molecular weight
- 384.24
- Formula
- C19H25BN4O4
- Solubility
- ≥ 19·212mg/mL in DMSO
- InChIKey
- GXJABQQUPOEUTA-RDJZCZTQSA-N
- Catalogue number
- GC17644
- Brand
- GLPBIO
Computed properties PubChem CID 387447 · TPSA 124 Ų · H-bond donors 4 · H-bond acceptors 6
- TPSA
- 124 Ų
- H-bond donors
- 4
- H-bond acceptors
- 6
- Rotatable bonds
- 9
- Heavy atoms
- 28
SMILES B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
Computed descriptors from PubChem (CID 387447), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il